Search results
Bristol-Myers Squibb Insiders Sell US$1.1m Of Stock, Possibly Signalling Caution
Simply Wall St. via Yahoo Finance· 8 hours agoMany Bristol-Myers Squibb Company (NYSE:BMY) insiders ditched their stock over the past year, which...
Bristol-Myers Squibb (NYSE:BMY) shareholders have endured a 33% loss from investing in the stock a...
Simply Wall St. via Yahoo Finance· 4 days agoIt's easy to match the overall market return by buying an index fund. When you buy individual...
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month - Enovis (NYSE:ENOV),...
Benzinga· 1 day agoLoading... Loading... The most oversold stocks in the health care sector presents an opportunity to...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoNew York, USA, May 06, 2024 (GLOBE NEWSWIRE) -- Global Liver Disease Therapeutics Market to Grow Rapidly by 2030, Examines DelveInsight | Key Players in the Market - AbbVie, GSK, F.Hoffmann-La Roche, Bristol-Myers Squibb Company, Abbott, Gilead
Fisher Asset Management LLC Acquires 127,228 Shares of Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 2 days agoFisher Asset Management LLC increased its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 130.7% in the 4th quarter, according to the company in its most recent filing with the ...
Investors Purchase Large Volume of Bristol-Myers Squibb Put Options (NYSE:BMY)
ETF DAILY NEWS· 6 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) saw some unusual options trading on Wednesday. Investors bought 69,538 put options on the company. This represents an increase of 76% compared ...
Bristol-Myers Squibb (NYSE:BMY) Given Average Rating of “Hold” by Analysts
ETF DAILY NEWS· 6 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) has earned an average rating of “Hold” from the nineteen ratings firms that are currently covering the firm, MarketBeat.com reports. One research ...
Pharma R&D productivity seen improving for the first time in years
Seeking Alpha· 4 days agoDiscover the latest findings on the return on investment from pharmaceutical...
McAdam LLC Reduces Holdings in Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 7 days agoMcAdam LLC decreased its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 6.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities ...
Leukemia Therapeutics Market Expected to Grow at USD 13491.42 Million by 2030: SNS Insider
Digital Journal· 5 days agoThe global leukemia therapeutics market has witnessed significant growth in recent years, driven by...